Order Article Reprints

Apostolou P, Dellatola V, Papadimitriou C, Kalfakakou D, Fountzilas E, Faliakou E, Fountzilas G, Romanidou O, Konstantopoulou I, Fostira F. CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects. Cancers. 2021; 13(9):2106. https://doi.org/10.3390/cancers13092106

Apostolou, Paraskevi, Vasiliki Dellatola, Christos Papadimitriou, Despoina Kalfakakou, Elena Fountzilas, Eleni Faliakou, Georgios Fountzilas, Ourania Romanidou, Irene Konstantopoulou, and Florentia Fostira. 2021. "CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects" Cancers 13, no. 9: 2106. https://doi.org/10.3390/cancers13092106

Apostolou, P., Dellatola, V., Papadimitriou, C., Kalfakakou, D., Fountzilas, E., Faliakou, E., Fountzilas, G., Romanidou, O., Konstantopoulou, I., & Fostira, F. (2021). CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects. Cancers, 13(9), 2106. https://doi.org/10.3390/cancers13092106